Page last updated: 2024-09-03

n-acetyllactosamine and Stomach Neoplasms

n-acetyllactosamine has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mare, L; Trinchera, M1

Other Studies

1 other study(ies) available for n-acetyllactosamine and Stomach Neoplasms

ArticleYear
Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans.
    European journal of biochemistry, 2004, Volume: 271, Issue:1

    Topics: Adenocarcinoma; Amino Sugars; Base Sequence; Carbohydrate Sequence; Colonic Neoplasms; DNA Primers; DNA, Antisense; Galactose; Galactosyltransferases; Glycopeptides; Glycosylation; Humans; Molecular Sequence Data; Oligosaccharides; Polysaccharides; Promoter Regions, Genetic; Sialyl Lewis X Antigen; Stomach Neoplasms; Suppression, Genetic; Tumor Cells, Cultured

2004